Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type; End-use; By Region; Segment Forecast, 2023 - 2032

Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type; End-use; By Region; Segment Forecast, 2023 - 2032



The global infection control market size is expected to reach USD 400.81 billion by 2032, according to a new study by Polaris Market Research. The report “Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type (Equipment, Services, Consumables, Others); End-use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rise in surgical procedures that require rigorous infection control is the main factor driving the market. The positive therapeutic outcomes produced using infection control are regarded to be the cause of the high preference. The COVID-19 pandemic has positively impacted market growth due to the rise in demand for sterilization and disinfection in hospitals and clinics, pharmaceutical and medical device sectors.

According to the WHO's practical advice on the prevention of HAI, the extra amount of time spent in the hospital due to surgical infections was estimated to be around 8 days. These prolonged stays are anticipated to result in a large increase in hospital costs, which heightens the clinical urgency for implementing infection prevention measures. It is anticipated that prolonged hospital stays are not cost-effective for hospitals and healthcare payers as a result of the excessive use of resources to treat the acquired infection.

The market for infection control on a global scale is competitive and only somewhat fragmented. Industry participants are focusing on new product releases, product developments, and global growth in order to improve their market share. Some of the key players in the market include Fortive (Advanced Sterilization Products), 3M Company, Getinge AB, Steris PLC, and Cantel Medical Corporation.

Diseases include pneumonia, infections of the bloodstream, urinary tract, surgical site, and MRSA are the main causes of hospital-acquired infections. Other prominent hospital-acquired infections (HAI) include catheter-related bloodstreams, catheter-associated urinary tract infections, and pneumonia related to ventilators. HAI is one of the major problems that hinders patient recovery and significantly affects death rates globally.

Infection Control Market Report Highlights

Hospitals held the biggest revenue share in 2022 and are projected to grow at the fastest rate (CAGR) throughout the course of the forecast period. The significant portion of infections is primarily due to the high risk of contracting diseases on hospital property through respiratory or bloodborne pathogen transmission.

North America led the industry share in 2022. The increased market share that this sector has managed to capture is regarded to be a result of a consistent number of strategic partnerships taken up by major market participants to increase their product offering and infection control capabilities. The greater efforts made by existing companies to establish themselves throughout this region are also to blame for North America's dominant market share.

3M Corporation, Belimed AG, Halyard Health, Getinge Group, Matachana Group, and others are some of the leading companies competing in the international market.

Polaris Market Research has segmented the Infection Control Market report based on type, end-use, and region:

Infection Control Market, Type (Revenue - USD Billion, 2019 - 2032)

Equipment

Services

Consumables

Others

Infection Control Market, End Use (Revenue - USD Billion, 2019 - 2032)

Hospital

Medical Device Company

Pharmaceutical Laboratories

Infection Control Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Infection Control Market Insights
4.1. Infection Control Market – Industry Snapshot
4.2. Infection Control Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increase of surgical procedures that demand intensive infection control
4.2.1.2. Rising involvement of government agencies
4.2.2. Restraints and Challenges
4.2.2.1. High cost
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Infection Control Industry trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Infection Control Market, by Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Infection Control, by Type, 2019-2032 (USD Billion)
5.3. Equipment
5.3.1. Global Infection Control Market, by Equipment, by Region, 2019-2032 (USD Billion)
5.4. Services
5.4.1. Global Infection Control Market, by Services, by Region, 2019-2032 (USD Billion)
5.5. Consumables
5.5.1. Global Infection Control Market, by Consumables, by Region, 2019-2032 (USD Billion)
5.6. Others
5.6.1. Global Infection Control Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Infection Control Market, by End-Use
6.1. Key Findings
6.2. Introduction
6.2.1. Global Infection Control Market, by End-Use, 2019-2032 (USD Billion)
6.3. Hospitals
6.3.1. Global Infection Control Market, by Hospitals, by Region, 2019-2032 (USD Billion)
6.4. Medical Device Companies
6.4.1. Global Infection Control Market, by Medical Device Companies, by Region, 2019-2032 (USD Billion)
6.5. Clinical Laboratories
6.5.1. Global Infection Control Market, by Clinical Laboratories, by Region, 2019-2032 (USD Billion)
6.6. Pharmaceutical Laboratories
6.6.1. Global Infection Control Market, by Pharmaceutical Laboratories, by Region, 2019-2032 (USD Billion)
6.7. Others
6.7.1. Global Infection Control Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Infection Control Market, by Geography
7.1. Key findings
7.2. Introduction
7.2.1. Infection Control Market Assessment, By Geography, 2019-2032 (USD Billion)
7.3. Infection Control Market – North America
7.3.1. North America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.3.2. North America: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.3.3. Infection Control Market – U.S.
7.3.3.1. U.S.: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.3.3.2. U.S.: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.3.4. Infection Control Market – Canada
7.3.4.1. Canada: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.3.4.2. Canada: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.4. Infection Control Market – Europe
7.4.1. Europe: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.4.2. Europe: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.4.3. Infection Control Market – UK
7.4.3.1. UK: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.4.3.2. UK: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.4.4. Infection Control Market – France
7.4.4.1. France: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.4.4.2. France: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.4.5. Infection Control Market – Germany
7.4.5.1. Germany: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.4.5.2. Germany: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.4.6. Infection Control Market – Italy
7.4.6.1. Italy: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.4.6.2. Italy: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.4.7. Infection Control Market – Spain
7.4.7.1. Spain: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.4.7.2. Spain: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.4.8. Infection Control Market – Netherlands
7.4.8.1. Netherlands: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.4.8.2. Netherlands: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.4.9. Infection Control Market – Russia
7.4.9.1. Russia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.4.9.2. Russia: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.5. Infection Control Market – Asia Pacific
7.5.1. Asia Pacific: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.5.2. Asia Pacific: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.5.3. Infection Control Market – China
7.5.3.1. China: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.5.3.2. China: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.5.4. Infection Control Market – India
7.5.4.1. India: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.5.4.2. India: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.5.5. Infection Control Market – Malaysia
7.5.5.1. Malaysia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.5.5.2. Malaysia: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.5.6. Infection Control Market – Japan
7.5.6.1. Japan: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.5.6.2. Japan: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.5.7. Infection Control Market – Indonesia
7.5.7.1. Indonesia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.5.7.2. Indonesia: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.5.8. Infection Control Market – South Korea
7.5.8.1. South Korea: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.5.8.2. South Korea: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.6. Infection Control Market – Middle East & Africa
7.6.1. Middle East & Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.6.2. Middle East & Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.6.3. Infection Control Market – Saudi Arabia
7.6.3.1. Saudi Arabia: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.6.3.2. Saudi Arabia: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.6.4. Infection Control Market – UAE
7.6.4.1. UAE: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.6.4.2. UAE: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.6.5. Infection Control Market – Israel
7.6.5.1. Israel: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.6.5.2. Israel: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.6.6. Infection Control Market – South Africa
7.6.6.1. South Africa: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.6.6.2. South Africa: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.7. Infection Control Market – Latin America
7.7.1. Latin America: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.7.2. Latin America: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.7.3. Infection Control Market – Mexico
7.7.3.1. Mexico: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.7.3.2. Mexico: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.7.4. Infection Control Market – Brazil
7.7.4.1. Brazil: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.7.4.2. Brazil: Infection Control Market, by Type, 2019-2032 (USD Billion)
7.7.5. Infection Control Market – Argentina
7.7.5.1. Argentina: Infection Control Market, by End-Use, 2019-2032 (USD Billion)
7.7.5.2. Argentina: Infection Control Market, by Type, 2019-2032 (USD Billion)
8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
9.1. 3M Company
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Development
9.2. Belimed AG
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Development
9.3. Halyard Health
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Development
9.4. Getinge Group
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Development
9.5. Matachana Group
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings